Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Bellone

Showing results (81-90 of 85) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 85 results.
Blood|April 29, 2025
The mitochondrial protease ClpP is a metabolic vulnerability and an immunogenic trigger against multiple myelomaTommaso Perini, Paola Zordan, Rossella Del Pizzo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 6, 2024
First Results of NURE-Combo: A Phase II Study of Neoadjuvant Nivolumab and Nab-Paclitaxel, Followed by Postsurgical Adjuvant Nivolumab, for Muscle-Invasive Bladder CancerChiara Mercinelli, Marco Moschini, Antonio Cigliola, et al.
Cancer Research|March 5, 2026
Intercepting YAP Activation in Prostate Cancer Blocks Neuroendocrine ProgressionArianna Brevi, Marco Lorenzoni, Sara Caputo, et al.
Science (New York, N.Y.)|October 7, 2021
Commensal bacteria promote endocrine resistance in prostate cancer through androgen biosynthesisNicolò Pernigoni, Elena Zagato, Arianna Calcinotto, et al.
Cancer Discovery|December 4, 2025
A High-Fiber Plant-Based Diet in Myeloma Precursor Disorders - Results from the NUTRIVENTION Clinical Trial and Preclinical Vk*MYC ModelUrvi A Shah, Laura Lucia Cogrossi, Juan-Jose Garces, et al.
Pageof 9

Showing results (81-90 of 85) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 85 results.
Blood|April 29, 2025
The mitochondrial protease ClpP is a metabolic vulnerability and an immunogenic trigger against multiple myelomaTommaso Perini, Paola Zordan, Rossella Del Pizzo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 6, 2024
First Results of NURE-Combo: A Phase II Study of Neoadjuvant Nivolumab and Nab-Paclitaxel, Followed by Postsurgical Adjuvant Nivolumab, for Muscle-Invasive Bladder CancerChiara Mercinelli, Marco Moschini, Antonio Cigliola, et al.
Cancer Research|March 5, 2026
Intercepting YAP Activation in Prostate Cancer Blocks Neuroendocrine ProgressionArianna Brevi, Marco Lorenzoni, Sara Caputo, et al.
Science (New York, N.Y.)|October 7, 2021
Commensal bacteria promote endocrine resistance in prostate cancer through androgen biosynthesisNicolò Pernigoni, Elena Zagato, Arianna Calcinotto, et al.
Cancer Discovery|December 4, 2025
A High-Fiber Plant-Based Diet in Myeloma Precursor Disorders - Results from the NUTRIVENTION Clinical Trial and Preclinical Vk*MYC ModelUrvi A Shah, Laura Lucia Cogrossi, Juan-Jose Garces, et al.
Pageof 9